{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:03Z","timestamp":1784557023354,"version":"3.55.0"},"reference-count":10,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"\n Summary<\/jats:title>\n \n This case report describes a 54-year-old woman with multiple endocrine autoimmune pathologies and recurrent mucocutaneous\n Candida spp<\/jats:italic>\n . infections that were inappropriately attributed to her glycemic control. Following an allergic reaction over four decades later, the patient was referred to clinical immunology. The combination of persistent Candida infections, autoimmune endocrinopathies, and a positive family history prompted investigation for an inborn error of immunity (IEI). Genetic testing revealed a novel, missense mutation in STAT1. Functional analysis confirmed enhanced STAT1 protein phosphorylation, confirming a gain-of-function phenotype that explained her infectious and autoimmune manifestations. She was started on the JAK inhibitor, ruxolitinib, with clinical improvement. This case underscores the shared molecular mechanisms between IEIs and autoimmune endocrinopathies and highlights the importance of early recognition of IEI in patients with unusual or treatment-refractory infections alongside autoimmune disease. Endocrinologists and primary care providers may be the first to encounter such patients and should consider referral for immunologic and genetic evaluation. Early diagnosis can reduce long-term morbidity and open the door to targeted therapies that address the root cause of immune dysregulation.\n <\/jats:p>\n <\/jats:sec>\n \n Learning points<\/jats:title>\n \n \n Persistent mucocutaneous candidiasis in patients with autoimmune endocrinopathies warrants evaluation for underlying IEI: while candidiasis is common in individuals with diabetes, recurrent or treatment-refractory infections \u2013 particularly in the presence of additional autoimmune conditions \u2013 should prompt consideration of IEI, including STAT1 gain-of-function mutations.<\/jats:p>\n <\/jats:list-item>\n \n Autoimmunity and immunodeficiency represent overlapping spectra of immune dysregulation: genetic syndromes such as STAT1 GOF may manifest with both autoimmune endocrinopathies and increased susceptibility to fungal infections, underscoring the importance of a unifying diagnostic approach to seemingly disparate clinical features.<\/jats:p>\n <\/jats:list-item>\n \n Early referral to clinical immunology and genetic testing can enable timely diagnosis and targeted therapy: early recognition of IEI allows for disease-modifying treatment, such as JAK inhibition, which may alleviate infectious susceptibility and autoimmune manifestations, ultimately reducing morbidity and improving the quality of life.<\/jats:p>\n <\/jats:list-item>\n \n A thorough family history can provide critical diagnostic clues in cases of immune dysregulation: subtle patterns of autoimmunity or recurrent infections in family members \u2013 particularly in non-consanguineous pedigrees \u2013 may indicate heritable immunologic disorders and should inform the clinical threshold for pursuing genetic evaluation.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>","DOI":"10.1530\/edm-25-0054","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:30:27Z","timestamp":1753356627000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Delayed diagnosis of STAT1 gain-of-function variant in a patient with multiple endocrine autoimmunity and recurrent fungal infections"],"prefix":"10.1530","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-9717","authenticated-orcid":true,"given":"Sydney","family":"Sparanese","sequence":"first","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae","family":"Brager","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Immunology, Allergy, and Dermatology, Hamilton Health Sciences, McMaster University, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fahmy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Clinical Immunology and Allergy, Hamilton Health Sciences, McMaster University, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Garkaby","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Immunology, Allergy, and Dermatology, Hamilton Health Sciences, McMaster University, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Endocr Rev","first-page":"789","article-title":"Thyroid dysfunction and diabetes mellitus: two closely associated disorders","volume":"40","author":"Biondi B","year":"2018","unstructured":"Biondi B\n, \nKahaly GJ\n & \nRobertson RP\n\n. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr Rev 2018 40 789\u2013824. (https:\/\/doi.org\/10.1210\/er.2018-00163)"},{"key":"bib2","series-title":"Diabetes Care","first-page":"2026","article-title":"Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association","volume":"41","author":"Chiang JL","year":"2018","unstructured":"Chiang JL\n, \nMaahs DM\n, \nGarvey KC\n, et al.\n Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care 2018 41 2026\u20132044. (https:\/\/doi.org\/10.2337\/dci18-0023)"},{"key":"bib3","series-title":"J Allergy Clin Immunol","first-page":"1388","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer A","year":"2017","unstructured":"Fischer A\n, \nProvot J\n, \nJais JP\n, et al.\n Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol 2017 140 1388\u20131393.e8. (https:\/\/doi.org\/10.1016\/j.jaci.2016.12.978)"},{"key":"bib4","series-title":"J Allergy Clin Immunol","first-page":"1629","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation","volume":"139","author":"Weinacht KG","year":"2017","unstructured":"Weinacht KG\n, \nCharbonnier LM\n, \nAlroqi F\n, et al.\n Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation. J Allergy Clin Immunol 2017 139 1629\u20131640.e2. (https:\/\/doi.org\/10.1016\/j.jaci.2016.11.022)"},{"key":"bib5","series-title":"N Engl J Med","first-page":"1829","article-title":"Clinical variation of autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen P","year":"1990","unstructured":"Ahonen P\n, \nMyll\u00e4rniemi S\n, \nSipil\u00e4 I\n, et al.\n Clinical variation of autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990 322 1829\u20131836. (https:\/\/doi.org\/10.1056\/nejm199006283222601)"},{"key":"bib6","series-title":"Clin Immunol","first-page":"34","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles C","year":"1999","unstructured":"Cunningham-Rundles C\n & \nBodian C\n\n. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999 92 34\u201348. (https:\/\/doi.org\/10.1006\/clim.1999.4725)"},{"key":"bib7","series-title":"Blood","first-page":"3154","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana J","year":"2016","unstructured":"Toubiana J\n, \nOkada S\n, \nHiller J\n, et al.\n Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood 2016 127 3154\u20133164. (https:\/\/doi.org\/10.1182\/blood-2015-11-679902)"},{"key":"bib8","series-title":"J Clin Immunol","article-title":"Patients with STAT1 gain-of-function mutations display increased apoptosis which is reversed by the JAK inhibitor ruxolitinib","volume":"44","author":"Dotta L","year":"2024","unstructured":"Dotta L\n, \nTodaro F\n, \nBaronio M\n, et al.\n Patients with STAT1 gain-of-function mutations display increased apoptosis which is reversed by the JAK inhibitor ruxolitinib. J Clin Immunol 2024 44 85. (https:\/\/doi.org\/10.1007\/s10875-024-01684-y)"},{"key":"bib9","series-title":"Med Mycol","first-page":"201","article-title":"Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer?","volume":"47","author":"Domingues-Ferreira M","year":"2009","unstructured":"Domingues-Ferreira M\n, \nGrumach AS\n, \nDuarte AJDS\n, et al.\n Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer? Med Mycol 2009 47 201\u2013205. (https:\/\/doi.org\/10.1080\/13693780802342545)"},{"key":"bib10","series-title":"N Engl J Med","first-page":"1494","article-title":"STAT1 gain of function, type 1 diabetes, and reversal with JAK inhibition","volume":"383","author":"Chaimowitz NS","year":"2020","unstructured":"Chaimowitz NS\n, \nEbenezer SJ\n, \nHanson IC\n, et al.\n STAT1 gain of function, type 1 diabetes, and reversal with JAK inhibition. N Engl J Med 2020 383 1494\u20131496. (https:\/\/doi.org\/10.1056\/nejmc2022226)"}],"container-title":["Endocrinology, Diabetes & Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2025\/3\/EDM-25-0054.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/3\/EDM-25-0054.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/3\/EDM-25-0054.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:37Z","timestamp":1784555317000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":10,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/edm-25-0054","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}